Rights Issue Prospectus
A prospectus in relation to ICSGlobal Limited's renounceable right issue was publicly issued, and lodged with the Australian Securities and Investments Commission, on 15 July 2009. Eligible shareholders are entitled to subscribe for two new share for every nine existing shares held at 7pm on the record date of 24 July 2009 at a issue price of $0.10 per new share. Only shareholders on the register on the record date with registered addresses in Australia or New Zealand are eligible to participate in the rights issue.
The maximum shares that may be issued under the offer is 33,330,216, raising (if fully subscribed) approximately $3.33 million before expenses. The rights issue is partially underwritten to the amount of $960,000.The funds raised from the rights issue will be primarily used to
- providing funding for potential acquisitions of profitable medical billing companies in the United States;
- supplement the company's working capital
The Prospectus is an important document. You should read it in its entirety and consider the risk factors that could affect the performance of ICSGlobal Limited before deciding whether to invest in ICSGlobal Limited.
An application for new shares under the rights issue by an eligible shareholder may only be made on an entitlement and acceptance form accompanying a hard copy of the rights issue Prospectus sent to the eligible shareholder.
New shares offered under the Prospectus may only be issued by ICSGlobal Limited in response to application form issued together with the Prospectus where ICSGlobal Limited has reasonable grounds to believe that the application form was included in, or accompanied by, a complete and unaltered copy of the Prospectus when the application form was distributed. A person who gives another person access to an application form must at the same time and by the same means give the other person access to the Prospectus. If any supplementary or replacement Prospectus is lodged in relation to the Prospectus, such documents will be made available on this website.
Warning
The Prospectus and other information provided on this website are available to residents of Australia accessing
this website in Australia. Due to regulatory requirements, the invitation to apply for new shares under the Prospectus
on this website is not extended to investors located or resident outside Australia. If you are accessing this site
from anywhere outside Australia DO NOT download, print or view the Prospectus accessible through this web page.
The distribution of the Prospectus available on this website in jurisdictions outside Australia may be restricted by
law and persons who come into possession of the Prospectus should seek advice on and must observe any such restrictions.
Any failure to comply with such restrictions may constitute a violation of applicable securities laws. The Prospectus
does not constitute an offer or invitation to potential investors in any place in which, or to any person to whom, it
would not be lawful to make such an offer or invitation. No action has been taken to register the shares or otherwise
permit an offering of the shares in any jurisdiction outside of Australia and New Zealand. The Prospectus does not
constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or to any US person.